Sulroin Posts ₩1.2B Operating Profit in Q1, Swings to Black

Sulroin, a food tech company revolutionizing the paradigm of the Hanwoo industry, succeeded in turning its first quarterly profit since its founding in Q1 2025, recording 22 billion KRW in revenue and 1.2 billion KRW in operating profit. This achievement, driven by the simultaneous growth of its proprietary D2C platform and B2B platform 'Bondaero', proves that Sulroin's unique business model is bearing fruit. Sulroin's differentiator lies in its food tech capabilities that go beyond simple distribution. Based on patented aging technology secured through in-house R&D, it develops high-quality Hanwoo products and directly manages the entire value chain from product manufacturing to sales. This is a key driver that allows it to secure both quality and price competitiveness, unlike conventional commerce companies. Furthermore, by successfully establishing strong nationwide branding instead of remaining regional, it is setting new standards for the Hanwoo market. The astonishing growth is clearly evident in the numbers. Following the achievement of 55.6 billion KRW in revenue in 2023, a 65% increase year-on-year, it already surpassed 22 billion KRW in Q1 2025, achieving 40% of the previous year's revenue in just one quarter. Considering the tendency for Hanwoo industry sales to concentrate in the second half of the year, achieving over 80 billion KRW in annual revenue and turning an annual profit in 2025 has become a very tangible goal. Behind this growth were thorough efforts to improve cost efficiency. The stabilization of the Gunpo Smart Factory, built with a total investment of 50 billion KRW, and the completion of IT development projects significantly reduced production and operating costs. Furthermore, realizing economies of scale through bulk purchasing reduced variable costs such as packaging materials and transportation fees, and as brand recognition spread, sales surged even without advertising expenses, demonstrating excellent cost efficiency. Byun Joon-won, CEO of Sulroin, stated, "Having firmly entered a profit growth trajectory through various challenges, Sulroin is currently in its final stage of capital raising," adding, "We will make every effort to prepare for a successful initial public offering (IPO) in 2026 with NH Investment & Securities as our lead underwriter." Sulroin is positioning itself as a company that leads the future food industry with technology and innovation, going beyond simple Hanwoo sales.